Characteristics | FH patients (n = 285) |
---|---|
Baseline Data | |
Male, n (%) | 173 (60.7%) |
Age, year | 49 ± 12 |
BMI, kg/(m2) | 25.32 ± 3.74 |
SBP, mm/Hg | 125 ± 17.0 |
DBP, mm/Hg | 78 ± 11.5 |
Glucose, mmol/L | 5.54 ± 1.47 |
Xanthoma, n(%) | 28 (9.8%) |
CAD, n (%) | 233 (81.8%) |
Family history of CAD, n (%) | 124 (43.5%) |
Region distribution | |
northeast China | 65 (22.8%) |
north China | 160 (56.1%) |
northwest China | 12 (4.2%) |
eastern China | 38 (13.3%) |
southern China | 8 (2.8%) |
southwest China | 2 (0.7%) |
Lipids | |
TC, mmol/L | 7.03 ± 2.53 |
HDL-C, mmol/L | 1.09 ± 0.32 |
LDL-C, mmol/L | 5.22 ± 2.12 |
Untreated LDL-C, mmol/L | 7.86 ± 2.25 |
TG, mmol/L | 1.67 (1.20–2.14) |
ApoA, g/L | 1.31 ± 0.33 |
ApoB, g/L | 1.47 ± 0.49 |
Statin, n (%) | 231 (81.1%) |
Ezetimibe, n (%) | 17 (6.0%) |